U.S. Global Investors (USGI)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,078
Closed -$383K 160
2019
Q2
$383K Buy
2,078
+139
+7% +$24.9K 0.2% 128
2019
Q1
$368K Sell
1,939
-665
-26% -$127K 0.18% 111
2018
Q4
$507K Hold
2,604
0.29% 88
2018
Q3
$540K Sell
2,604
-96
-4% -$18.9K 0.26% 85
2018
Q2
$498K Buy
2,700
+200
+8% +$35.4K 0.23% 94
2018
Q1
$426K Buy
2,500
+200
+9% +$36.7K 0.26% 83
2017
Q4
$400K Buy
+2,300
New +$407K 0.18% 102
2016
Q1
Sell
-1,300
Closed -$211K 188
2015
Q4
$211K Buy
+1,300
New +$204K 0.11% 166
2014
Q2
Sell
-7,500
Closed -$925K 293
2014
Q1
$925K Buy
7,500
+3,500
+88% +$424K 0.15% 138
2013
Q4
$457K Buy
4,000
+500
+14% +$56.9K 0.08% 175
2013
Q3
$391K Sell
3,500
-3,600
-51% -$390K 0.07% 172
2013
Q2
$701K Buy
+7,100
New +$737K 0.12% 136

Other funds holding AMGN

U.S. Global Investors (USGI)'s AMGN Position: Q3 2019 in Review

U.S. Global Investors (USGI) sold out of Amgen (AMGN) in Q3 2019, closing a stake of 2,078 shares — an estimated $383K sold.

U.S. Global Investors (USGI) first reported a position in AMGN in Q2 2013 and held it in 12 quarters. The position peaked at $925K in Q1 2014. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • U.S. Global Investors (USGI) reported no remaining Amgen position as of Q3 2019 after selling out during the quarter.
  • U.S. Global Investors (USGI) sold 2,078 Amgen shares in Q3 2019, an estimated $383K.
  • U.S. Global Investors (USGI) first reported a position in Amgen in Q2 2013 and held it in 12 quarters.
  • U.S. Global Investors (USGI)'s Amgen position peaked at $925K in Q1 2014.
  • 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on U.S. Global Investors (USGI)'s 13F filing for Q3 2019, filed 12 Nov 2019.